Author

E. Reyes

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell signaling & trafficking· 2 Approach:experimental assay· 2 Organism:mouse· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Assay:flow cytometry· 1 Research Focus:host-pathogen & immune response· 1 Assay:proteomics· 1

Frequent Co-Authors

B. E. Fee· 1 shared D. C. Ko· 1 shared D. N. Cook· 1 shared D. Wang· 1 shared E. Hauser· 1 shared G. A. Taylor· 1 shared G. E. Hammer· 1 shared H.-I. Huang· 1 shared

Activity by Year

2019-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

B. E. Fee

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Th17 immunity in the colon is controlled by two novel subsets of colon-specific mononuclear phagocytes

H.-I. Huang, M. L. Jewell, N. Youssef, M.-N. Huang, E. Hauser, B. E. Fee, N. P. Rudemiller, J. Privratsky, J. J. Zhang, E. Reyes, D. Wang, G. A. Taylor, M. D. Gunn, D. C. Ko, D. N. Cook, , G. E. Hammer

This study identifies two novel colon-specific mononuclear phagocyte subsets that are critical for Th17 immunity in the colon.

bioRxiv · Jan 28, 2021Immunology

Lactoferrin Reverses Methotrexate Driven Epithelial Barrier Defect by Inhibiting TGF-β Mediated Epithelial to Mesenchymal Transition

T. Wallach, V. Srivastava, E. Reyes, O. D. Klein, Z. J. Gartner

This study shows lactoferrin reverses methotrexate-induced epithelial barrier defects by inhibiting TGF-β mediated epithelial-mesenchymal transition in intestinal models.

bioRxiv · Dec 23, 2019 · PreprintCell Biology